Die FeLV-Infektion bei der Katze – ein Update

Aufgrund der unterschiedlichen möglichen Infektionsverläufe sowie der verschiedenen verfügbaren Testverfahren ist es nicht immer einfach, eine FeLV-Infektion korrekt zu diagnostizieren. Da eine kausale Therapie nicht existiert, sind das Management infizierter Katzen und der Schutz infektionsgefährdeter Tiere essenziell.

Publikationsverlauf

Artikel online veröffentlicht:
26. August 2025

• Literatur

• 1 Lutz H, Addie D, Belák S. et al. Feline leukaemia. ABCD guidelines on prevention and management. J Feline Med Surg 2009; 11: 565-574 https://www.abcdcatsvets.org/wp-content/uploads/2023/01/ABCD-FeLV-Guideline-2021.pdf Updated 2015, last updated 2021 von Hartmann K, Hofmann-Lehmann R.; Stand 31.03.2025
• 2 Studer N, Lutz H, Saegerman C. et al. Pan-European Study on the Prevalence of the Feline Leukaemia Virus Infection – Reported by the European Advisory Board on Cat Diseases (ABCD Europe). Viruses 2019; 11: 993
• 3 Gleich SE, Krieger S, Hartmann K. Prevalence of feline immunodeficiency virus and feline leukaemia virus among client-owned cats and risk factors for infection in Germany. J Feline Med Surg 2009; 11: 985-992
• 4 Giselbrecht J, Jähne S, Bergmann M. et al. Prevalence of Different Courses of Feline Leukaemia Virus Infection in Four European Countries. Viruses 2023; 15: 1718
• 5 Sykes JE. Hrsg. Greeneʼs Infectious Diseases of the Dog and Cat [Ebook]. 5. Aufl.. Elsevier Health Sciences; 2022
• 6 Kessler M. Hrsg. Kleintieronkologie. Diagnose und Therapie von Tumorerkrankungen bei Hund und Katze. 4. Aufl.. Stuttgart: Thieme; 2022
• 7 Hartmann K. Clinical aspects of feline retroviruses: a review. Viruses 2012; 4: 2684-2710
• 8 Meichner K, Kruse DB, Hirschberger J. et al. Changes in prevalence of progressive feline leukaemia virus infection in cats with lymphoma in Germany. Vet Rec 2012; 171: 348
• 9 Tailor CS, Willett BJ, Kabat D. A Putative Cell Surface Receptor for Anemia-Inducing Feline Leukemia Virus Subgroup C Is a Member of a Transporter Superfamily. J Virol 1999; 73: 6500-6505
• 10 Sykes JE, Hartmann K. Feline Leukemia Virus Infection. In: Sykes JE. Hrsg. Canine and Feline Infectious Diseases. Philadelphia (PA): Saunders Elsevier; 2014: 224-238
• 11 Shelton GH, Linenberger ML. Hematologic abnormalities associated with retroviral infections in the cat. Semin Vet Med Surg Small Anim 1995; 10: 220-233
• 12 Levy JK, Scott HM, Lachtara JL. et al. Seroprevalence of feline leukemia virus and feline immunodeficiency virus infection among cats in North America and risk factors for seropositivity. J Am Vet Med Assoc 2006; 228: 371-376
• 13 Nesina S, Helfer-Hungerbuehler AK, Riond B. et al. Retroviral DNA–the silent winner: blood transfusion containing latent feline leukemia provirus causes infection and disease in naïve recipient cats. Retrovirology 2015; 12: 105
• 14 Pacitti AM, Jarrett O, Hay D. Transmission of feline leukaemia virus in the milk of a non-viraemic cat. Vet Rec 1986; 118: 381-384
• 15 Westman ME, Malik R, Hall E. et al. Comparison of three feline leukaemia virus (FeLV) point-of-care antigen test kits using blood and saliva. Comp Immunol Microbiol Infect Dis 2017; 50: 88-96
• 16 Sand C, Englert T, Egberink H. et al. Evaluation of a new in-clinic test system to detect feline immunodeficiency virus and feline leukemia virus infection. Vet Clin Pathol 2010; 39: 210-214
• 17 Little S, Levy J, Hartmann K. et al. 2020 AAFP Feline Retrovirus Testing and Management Guidelines. J Feline Med Surg 2020; 22: 5-30
• 18 Hofmann-Lehmann R, Hartmann K. Feline leukaemia virus infection: A practical approach to diagnosis. J Feline Med Surg 2020; 22: 831-846
• 19 Hofmann-Lehmann R, Huder JB, Gruber S. et al. Feline leukaemia provirus load during the course of experimental infection and in naturally infected cats. J Gen Virol 2001; 82: 1589-1596
• 20 Beall MJ, Buch J, Cahill RJ. et al. Evaluation of a quantitative enzyme-linked immunosorbent assay for feline leukemia virus p 27 antigen and comparison to proviral DNA loads by real-time polymerase chain reaction. Comp Immunol Microbiol Infect Dis 2019; 67: 101348
• 21 Giselbrecht J, Jähne S, Bergmann M. et al. Evaluation of a Revised Point-of-Care Test for the Detection of Feline Leukaemia p 27 Antigen and Anti-p 15E Antibodies in Cats. Viruses 2024; 16: 614
• 22 Westman ME, Giselbrecht J, Norris JM. et al. Field Performance of a Rapid Test to Detect Progressive, Regressive, and Abortive Feline Leukemia Virus Infections in Domestic Cats in Australia and Germany. Viruses 2023; 15: 491
• 23 StIKo Vet am FLI. Impfleitlinie für Kleintiere (06.01.2025). https://www.tieraerzteverband.de/bpt/berufspolitik/leitlinien/dokumente/impfleitlinien/Impfleitlinie_Kleintiere_2025-01-06.pdf Stand: 06.03.2025
• 24 Hartmann K. Regressive and progressive feline leukemia virus infections – clinical relevance and implications for prevention and treatment. Thai J Vet Med Suppl 2017; 47: 109-112 https://wendyblount.com/articles/hematology/2Article-TJVMS-RegressiveFeLV.pdf Stand: 06.03.2025
• 25 Hartmann K, Day MJ, Thiry E. et al. Feline injection-site sarcoma: ABCD guidelines on prevention and management. J Feline Med Surg 2015; 17: 606-613
• 26 Hartmann K. Efficacy of antiviral chemotherapy for retrovirus-infected cats: What does the current literature tell us?. J Feline Med Surg 2015; 17: 925-939
• 27 Westman ME, Hall E, Norris JM. et al. Antiviral therapy in cats progressively infected with feline leukaemia virus: lessons from a series of 18 consecutive cases from Australia. Aust Vet J 2024; 102: 453-465
• 28 Boesch A, Cattori V, Riond B. et al. Evaluation of the effect of short-term treatment with the integrase inhibitor raltegravir (Isentress) on the course of progressive feline leukemia virus infection. Vet Microbiol 2015; 175: 167-178
• 29 Santos CRGR, Ferreira IT, Beranger R. et al. Undetectable proviral DNA and viral RNA levels after raltegravir administration in two cats with natural feline leukemia virus infection. Braz J Vet Med 2022; 44: e003522
• 30 Huan UE, Da Silva PMF, Floriano AP. Case studies on RetroMAD1^™, an orally administered recombinant chimeric protein to treat naturally infected Feline Leukemia Virus (FeLV) cats. Arch Vet Sci Med 2019; 2: 41-57
• 31 Mari K de Maynard L, Sanquer A. et al. Therapeutic effects of recombinant feline interferon-omega on feline leukemia virus (FeLV)-infected and FeLV/feline immunodeficiency virus (FIV)-coinfected symptomatic cats. J Vet Intern Med 2004; 18: 477-482
• 32 Doménech A, Miró G, Collado VM. et al. Use of recombinant interferon omega in feline retrovirosis: from theory to practice. Vet Immunol Immunopathol 2011; 143: 301-306